We're Hopeful That Denali Therapeutics (NASDAQ:DNLI) Will Use Its Cash Wisely

Yahoo FinanceNov 15 21:29

Denali Therapeutics Insider Sold Shares Worth $1,932,665, According to a Recent SEC Filing

MT NewswiresNov 14 08:06

BofA Securities Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Raises Target Price to $34

Futu NewsNov 13 11:32 · Ratings

Denali Therapeutics: Promising Pipeline and Strategic Advancements Justify Buy Rating

TipRanksNov 11 14:30 · Ratings

B.Riley Financial Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Maintains Target Price $33

Futu NewsNov 8 22:38 · Ratings

Denali Q3 Earnings Miss Estimates, Pipeline Progress Encouraging

Zacks Nov 8 22:35